GBM:

Mrinal K Ghosh1, Sunny Kumar1, Sabana Begam1

  • 1Cancer Biology and Inflammatory Disorder Division, Council of Scientific and Industrial Research-Indian Institute of Chemical Biology (CSIR-IICB), TRUE Campus, CN-6, Sector-V, Salt Lake, Kolkata 700091, India; Academy of Scientific and Innovative Research, Ghaziabad, Uttar Pradesh 201002, India.

Life sciences
|August 30, 2024
PubMed
概括

质母细胞瘤 (GBM) 免疫疗法有望改善患者的生存率,尽管存在诸如血脑屏障等挑战. 正在探索组合方法以提高治疗疗效.